$ cat ./records/gates-foundation-funds-anti-tick-mrna-vaccine-research-to-block-l-2023.txt
Gates Foundation funds anti-tick mRNA vaccine research to block Lyme disease transmission
[RECORD.TXT] · cat --full
The Gates Foundation provided funding for mRNA-based tick-bite vaccines at Yale University that train the immune system to react to tick saliva, causing ticks to detach before transmitting Lyme disease or other pathogens. Rather than targeting a single pathogen, this approach aims to block all tick-borne disease transmission simultaneously. Lyme disease infects approximately 476,000 Americans annually.
Source: https://www.gatesfoundation.org/about/committed-grants/2023/02/opp1218012
Free forever · No ads · Solo developer
If this was worth a read, help make the next entry possible.
Every entry in this archive was researched, verified, and written by one person — for free. No corporate funding. No ad revenue. Just a developer who believes verified history should be accessible to everyone. Your donation directly funds new entries.
Crypto accepted · No subscription required
← Previous
Publishes 'The Age of AI Has Begun,' declaring AI the most transformative technology since the GUI
Next →
WHO approves R21 malaria vaccine — the second ever — backed by Gates Foundation funding
[CROSS_REFERENCES] · grep --category='Global Health'
Related Accomplishments
January 2026
Gates-backed World Mosquito Program reaches 16 million people protected from dengue via Wolbachia method
The World Mosquito Program — backed in part by the Gates Foundation — announced in January 2026 that its Wolbachia-infected mosquito releases had reached over 16.1 million people across multiple countries, including Colombia, Indonesia, Brazil, Sri Lanka, Fiji, Vanuatu, and Vietnam. Wolbachia-carrying Aedes aegypti mosquitoes — which block dengue, Zika, chikungunya, and yellow fever transmission — had established self-sustaining populations in treated cities without requiring ongoing releases. Gold-standard randomised trials in Indonesia showed a 77% reduction in dengue incidence. The program represented one of the largest and most cost-effective vector control deployments in history.
2025
Gates-Funded Monoclonal Antibody Shows Early Promise as a Single-Shot Malaria Shield
[ARCHIVE_FUNDING] · INDEPENDENT · NO ADS
One developer. >300 verified entries. Zero ads. Forever free.
No sponsors, no paywall, no algorithm. If this archive has been useful to you, reader support is what keeps it running.